Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin

Archives of Disease in Childhood

Volumn 94, Issue 7, 2009, Pages 501-505

  Olaciregui Echenique, Izaskun ^a   Hernandez U ^a   Munoz J A ^a   Emparanza, J I ^a   Landa, J J ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BLOOD CULTURE; CELLULITIS; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; EMERGENCY WARD; FEMALE; GASTROENTERITIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SEPSIS; URINARY TRACT INFECTION; VIRUS INFECTION;

BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE; SPAIN;

EID: 67649678797     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.146530     Document Type: Article

References (35)

1. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 1993;92:1-12. (Pubitemid 23188860)
2. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med 2000;36:602-614
3. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med 1993;329:1437-1441 (Pubitemid 23335888)
4. Baker MD, Bell LM, Avner JR. The efficacy of routine outpatient management without antibiotics of fever in selected infants. Pediatrics 1999;103:627-631 (Pubitemid 29274511)
5. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 2001;108:311-316 (Pubitemid 32747340)
6. Long SS. Approach to the febrile patient with no obvious focus of infection. Pediatr Rev 1984;5:305-315
7. Dagan R, Powell KR, Hall KB, et al. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr 1985;107:855-860 (Pubitemid 16197090)
8. Dagan R, Sofer S, Phillip M, et al. Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections. J Pediatr 1988;112:355-360 (Pubitemid 18079815)
9. Jaskiewitz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Pediatrics 1994;94:390-396 (Pubitemid 24271486)
10. Kourtis AP, Sullivan DT, Sathian U. Practice guidelines for the management of febrile infants less than 90 days of age at the ambulatory network of a large pediatric health care system in the United States: Summary of new evidence. Clin Pediatr 2004;43:11-16. (Pubitemid 38112261)
11. Pulliam PN, Attia MW, Cronan KM, et al. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 2001;108:1275-1279 (Pubitemid 33121468)
12. Hsiao AL, Baker MD. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr 2005;17:56-61.
13. Grendel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-alpha for differentiation of bacterial versus viral infections. Pediatr Infect Dis J 1999;18:875-881 (Pubitemid 29487507)
14. Grendel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000;19:679-688 (Pubitemid 30644033)
15. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-746 (Pubitemid 27364784)
16. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217 (Pubitemid 38971491)
17. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-1608
18. Van Rossum AMC, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004;4:620-630 (Pubitemid 39296836)
19. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256
20. Gajdos V, Foix L'Hèlias L, Mollet-Boudjemline A, et al. Factors predicting serious bacterial infections in febrile infants less than three months old: multivariate analysis. Arch Pediatr 2005;12:397-403. (Pubitemid 40460349)
21. Maniaci V, Dauber A, Weiss S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008;122:701-710
22. Cuello CA, Tamez L, Valdez J. Total white blood cell count, erythrosedimentation rate and C-reactive protein for the detection of serious bacterial infections in 0 to 90 day old infants with fever without a source. An Pediatr Barc 2008;68:103-109 (Pubitemid 351362784)
23. Isaacman DJ, Burke BL. Utility of serum C-reactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med 2002;156:905-909 (Pubitemid 36343502)
24. Galetto-Lacour A, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001;160:95-100. (Pubitemid 32204534)
25. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003;112:1054-1060 (Pubitemid 37339556)
26. Thayyil S, Shenoy M, Hamaluba M, et al. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005;94:155-158
27. Andreola B, Bressan S, Callegaro S, et al. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007;26:672-677 (Pubitemid 47424634)
28. Fernández A, Luaces C, Valls C, et al. Use of procalcitonin in a pediatric emergency department in the early detection of invasive bacterial infection in infants. An Esp Pediatr 2001;55:321-328 (Pubitemid 34836009)
29. Fernández A, Luaces C, García JJ, et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 2003;22:895-903. (Pubitemid 37288613)
30. Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007;33:477-484 (Pubitemid 46333842)
31. Hatherill M, Tibby SM, Sykes K, et al. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999;81:417-421 (Pubitemid 29501374)
32. Casado-Flores J, Blanco-Quiros A, Asensio J, et al. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 2003;4:190-195
33. Fioretto JR, Borin FC, Bonatto RC, et al. Procalcitonin in children with sepsis and septic shock. J Pediatr (Rio J) 2007;83:323-328 (Pubitemid 47328113)
34. Herd D. In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus? Arch Dis Child 2007;92:362-365
35. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med 2008;36:941-952 Original article